These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2060176)

  • 1. Treatment and prevention of osteoporosis in juvenile chronic arthritis with disodium clodronate.
    Lepore L; Pennesi M; Barbi E; Pozzi R
    Clin Exp Rheumatol; 1991; 9 Suppl 6():33-5. PubMed ID: 2060176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphosphonate-induced radiographic changes in two pediatric patients with rheumatic diseases.
    Fernandes JL; Viana SL; Rocha AL; Ribeiro MC; Castro LC
    Skeletal Radiol; 2004 Dec; 33(12):732-6. PubMed ID: 15309334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors playing a role in the development of decreased bone mineral density in juvenile chronic arthritis.
    Celiker R; Bal S; Bakkaloğlu A; Ozaydin E; Coskun T; Cetin A; Dinçer F
    Rheumatol Int; 2003 May; 23(3):127-9. PubMed ID: 12739043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density and turnover in children with systemic juvenile chronic arthritis.
    Brik R; Keidar Z; Schapira D; Israel O
    J Rheumatol; 1998 May; 25(5):990-2. PubMed ID: 9598904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation by dual X-ray absorptiometry (DXA) of bone mineral density in children with juvenile chronic arthritis.
    Pereira RM; Corrente JE; Chahade WH; Yoshinari NH
    Clin Exp Rheumatol; 1998; 16(4):495-501. PubMed ID: 9706436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of rheumatic disease and corticosteroid treatment on calcium metabolism and bone density in children assessed one year after diagnosis, using stable isotopes and dual energy x-ray absorptiometry.
    Perez MD; Abrams SA; Loddeke L; Shypailo R; Ellis KJ
    J Rheumatol Suppl; 2000 Apr; 58():38-43. PubMed ID: 10782855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral metabolism in children with juvenile rheumatoid arthritis.
    Cassidy JT; Langman CB; Allen SH; Hillman LS
    Pediatr Clin North Am; 1995 Oct; 42(5):1017-33. PubMed ID: 7567184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations of bone density in patients with juvenile chronic arthritis by a sonographie method.
    Thiemann HH; John M; John V
    Acta Univ Carol Med (Praha); 1994; 40(1-4):37-41. PubMed ID: 9355670
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth retardation and osteoporosis in juvenile chronic arthritis.
    Woo PM
    Clin Exp Rheumatol; 1994; 12 Suppl 10():S87-90. PubMed ID: 7955635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral metabolism in juvenile chronic arthritis: the influence of steroids.
    Bardare M; Bianchi ML; Furia M; Gandolini GG; Cohen E; Montesano A
    Clin Exp Rheumatol; 1991; 9 Suppl 6():29-31. PubMed ID: 2060174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis in juvenile idiopathic arthritis.
    McDonagh JE
    Curr Opin Rheumatol; 2001 Sep; 13(5):399-404. PubMed ID: 11604595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis in childhood rheumatic diseases: prevention and therapy.
    Cimaz R
    Best Pract Res Clin Rheumatol; 2002 Jul; 16(3):397-409. PubMed ID: 12387807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological prevention of osteoporosis in patients on corticosteroid medication].
    Lems WF; Jacobs JW; Netelenbos JC; Dijkmans BA; Bijlsma JW
    Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1904-8. PubMed ID: 9856175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of cortisone-induced osteoporosis].
    Trombetti A; Ferrari S; Stoermann-Chopard C; Rizzoli R
    Praxis (Bern 1994); 2004 Mar; 93(11):407-14. PubMed ID: 15061108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates in the treatment of thalassemia-induced osteoporosis.
    Morabito N; Lasco A; Gaudio A; Crisafulli A; Di Pietro C; Meo A; Frisina N
    Osteoporos Int; 2002 Aug; 13(8):644-9. PubMed ID: 12181623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the protective effect of different intravenous bisphosphonates on the decrease in bone mineral density in patients submitted to radical prostatectomy undergoing androgen deprivation therapy. A prospective open-label controlled study.
    Rodrigues P; Hering FO; Bruna P; Meller A; Afonso Y
    Int J Urol; 2007 Apr; 14(4):317-20. PubMed ID: 17470161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bisphosphonate therapy in osteoporosis. Inhibition of trabecular perforation by aminobisphosphonate].
    Wüster C; Heilmann P
    Fortschr Med; 1997 Oct; 115(29):37-42. PubMed ID: 9445833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.
    Hodsman A; Adachi J; Olszynski W
    CMAJ; 1996 Oct; 155(7):945-8. PubMed ID: 8837544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rheumatoid arthritis and osteoporosis: trends in their treatments].
    Tanaka Y
    Nihon Rinsho; 2006 Dec; 64(12):2359-66. PubMed ID: 17154104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.